Effects of dexamethasone or methotrexate on chitinolytic activity in nasal polyps

American Journal of Rhinology and Allergy

Volumn 26, Issue 3, 2012, Pages 183-186

  Park, Seong Kook ^a   Hur, Dae Young ^a   Urm, Sang Hwa ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHITINASE; CHITOTRIOSIDASE; DEXAMETHASONE; METHOTREXATE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHITINOLYTIC ACTIVITY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; PH; TISSUE CULTURE;

ADULT; CELLS, CULTURED; CHITIN; CHITINASE; DEXAMETHASONE; FEMALE; HEXOSAMINIDASES; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; METHOTREXATE; MIDDLE AGED; NASAL POLYPS; ORGAN CULTURE TECHNIQUES;

EID: 84862182902     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3754     Document Type: Article

References (26)

1. Tharanthan RN, and Kittur FS. Chitin-The undisputed biomolecule of great potential. Crit Rev Food Sci Nutr 43:61-87, 2003. (Pubitemid 38552311)
2. Reese TA, Liang HE, Tager AM, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447:92-96, 2007. (Pubitemid 46685837)
3. Nio J, Fujimoto W, Konno A, et al. Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry. Histochem Cell Biol 121:473-482, 2004. (Pubitemid 38916435)
4. Boot RG, Blommaart EF, Swart E, et al. Identification of a novel acidic mammalian chitinase distinct from chitotirosidase. J Biol Chem 276: 6770-6778, 2001.
5. Mullol J, Obando A, Pujols L, et al. Corticosteroid treatment in chronic rhinosinusitis: The possibilities and the limits. Immunol Allergy Clin North Am 29:657-668, 2009.
6. Domingo CJ, Moreno A, Amengual MJ, et al. Twelve years' experience with methotrexate for GINA treatment step 5 asthma patients. Curr Med Res Opin 25:367-374, 2009.
7. Metzler C, Hellmich B, Gause A, et al. Churg Strauss Syndrome-Successful induction of remission with methotrexate and un expected high cardiac and pulmonary relapse ration during maintenance treatment. Clin Exp Rheumatol 22:S52-S61, 2004.
8. Buyukozturk S, Gelincik A, Aslan I, et al. Methotrexate: Can it be a choice for nasal polyposis in aspirin exacerbated respiratory disease? J Asthma 46:1037-1041, 2009.
9. Park SK, Heo KW, Hur DY, et al. Chitinolytic activity in nasal polyps. Am J Rhinol Allergy 25:12-14, 2011.
10. Park SK, Kim HI, Yang YI, et al. Effects of methotrexate on vascular endothelial growth factor, angiopoietin 1, and angiopoietin 2 in nasal polyps. Am J Rhinol Allergy 25:129-132, 2011.
11. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg 135(suppl):S31-S80, 2006. (Pubitemid 44647480)
12. Hollak CE, van Weely S, van Oers MH, et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288-1292, 1994.
13. Ramanathan M, and Lane AP. Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis. Otolaryngol Head Neck Surg 136:348-356, 2007. (Pubitemid 46282189)
14. Vinetz JM, and Kaslow DC. Plasmodium gallinaceum: Use of antisera to degenerate synthetic peptides derived from the active site of protozoal chitinases to characterize an ookinete-specific chitinase. Exp Parasitol 90:199-202, 1998. (Pubitemid 28471924)
15. Elias JA, Hormer RJ, Hamid Q, et al. Chitinases and chitinase-like proteins in TH2 inflammation and asthma. J Allergy Clin Immunol 116:497-500, 2005. (Pubitemid 41267117)
16. Shuhui L, Mok YK, and Fred Wong WS. Role of mammalian chitinases in asthma. Int Arch Allergy Immunol 149:369-377, 2009.
17. Lalaker A, Nkrumah L, Lee WK, et al. Chitin Stimulate expression of acidic mammalian chitinase and eotaxin-3 by human sinonasal epithelial cells in vitro. Am J Rhinol Allergy 23:8-14, 2009.
18. Smooak KA, and Cidlowski JA. Mechanism of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev 125:697-706, 2004. (Pubitemid 39482400)
19. Zhao J, Yeong LH, and Wong WS. Dexamethasone alters bronchoalveolar lavage fluid protome in a mouse asthma model. Int Arch Allergy Immunol 142:219-229, 2007.
20. Bucolo C, Musumeci M, Maltese A, et al. Effect of chitinase inhibitors on endotoxin-induced uveitis (EIU) in rabbits. Pharmacol Res 57:247-252, 2008.
21. Kuijpers AL, and van de kerkhof PC. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis. Am J Clin Dermatol 1:27-39, 2000.
22. Crostein BN. Low-dose methotrxate: A mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163-172, 2005.
23. Comet R, Domingo C, Larrosa M, et al Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double blind, randomized, placebo-controlled study. Respir Med 100:411-419, 2006. (Pubitemid 43239875)
24. Genestier L, Paillot R, Fournel S, et al. Immunosuppressive properties of methotrexateL apoptosis and clonal delection of activated peripheral T cells. J Clin Invest 102:322-328, 1998. (Pubitemid 28335191)
25. Morabito L, Montessinos MC, Schreibman DM, et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 295-300, 1998. (Pubitemid 28067325)
26. Goecke A, Alvarez C, Henriquez J, et al. Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell in vitro. Mol Immunol 44:2115-2123, 2007.